﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Academy of Medical Sciences of I.R. Iran</PublisherName>
      <JournalTitle>Archives of Iranian Medicine</JournalTitle>
      <Issn>1029-2977</Issn>
      <Volume>26</Volume>
      <Issue>8</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2023</Year>
        <Month>08</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Functional Variants in MicroRNAs (rs895819, rs11614913 and rs2910164) Are Associated with Susceptibility and Clinicopathological Features in Mexican Patients with Colorectal Cancer</ArticleTitle>
    <FirstPage>439</FirstPage>
    <LastPage>446</LastPage>
    <ELocationID EIdType="doi">10.34172/aim.2023.67</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Yuri Giovanna Vanessa</FirstName>
        <LastName>Trujillo-Fernández</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-9695-9771</Identifier>
      </Author>
      <Author>
        <FirstName>Carmen</FirstName>
        <LastName>Yzabal-Barbedillo</LastName>
      </Author>
      <Author>
        <FirstName>Anilú Margarita</FirstName>
        <LastName>Saucedo-Sarinaña</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-4097-8671</Identifier>
      </Author>
      <Author>
        <FirstName>César de Jesús</FirstName>
        <LastName>Tovar-Jácome</LastName>
      </Author>
      <Author>
        <FirstName>Miriam Yadira</FirstName>
        <LastName>Godínez-Rodríguez</LastName>
      </Author>
      <Author>
        <FirstName>Patricio</FirstName>
        <LastName>Barros-Núñez</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-6607-5553</Identifier>
      </Author>
      <Author>
        <FirstName>Martha Patricia</FirstName>
        <LastName>Gallegos-Arreola</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-4539-1693</Identifier>
      </Author>
      <Author>
        <FirstName>Clara Ibet</FirstName>
        <LastName>Juárez-Vázquez</LastName>
      </Author>
      <Author>
        <FirstName>Tomás Daniel</FirstName>
        <LastName>Pineda-Razo</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-6757-731X</Identifier>
      </Author>
      <Author>
        <FirstName>María Eugenia</FirstName>
        <LastName>Marín-Contreras</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-8352-236X</Identifier>
      </Author>
      <Author>
        <FirstName>Mónica Alejandra</FirstName>
        <LastName>Rosales-Reynoso</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-0387-4996</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/aim.2023.67</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2022</Year>
        <Month>12</Month>
        <Day>10</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2023</Year>
        <Month>07</Month>
        <Day>03</Day>
      </PubDate>
    </History>
    <Abstract>Background: miRNAs are non-coding RNAs participating actively in the post-translational regulation of oncogenes, tumor suppressor, and DNA repair genes implicated in colorectal cancer (CRC). This study aims to examine the association of the variants miR-27a (rs895819 A&gt;G), miR-196a2 (rs11614913 T&gt;G) and miR-146a (rs2910164 C&gt;G) in Mexican CRC patients. Methods: DNA samples from 183 patients and 186 healthy Mexican subjects were analyzed. Variants were identified by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) methodology. Association was calculated by the odds ratio (OR) and adjusted by the Bonferroni test. Results: Patients carrying the G/G genotype of the rs895819 variant in the miR-27a gene showed an increased risk of CRC (19% vs 12%, P=0.013). A similar tendency was noticed for patients younger than 50 years carrying A/G (48% vs 41%, P=0.014). The A/G genotype in TNM stages I+II (55.7% vs 40.8%, P=0.011) and tumor location in the colon (69.5 vs 40.8%, P=0.001) were also increased. For the variant rs11614913 of the miR-196a2 gene, carriers of the C/C genotype showed an increased risk of CRC (32% vs 22%, P=0.009). This genotype was more frequent in TNM stage III+IV (36.8% vs 22.5%, P=0.007) and the tumor had a more recurrent location in the rectum (31.6% vs 22.5%, P=0.013). The rs2910164 variant of the miR-146a gene was found to have no significant risk associations. Conclusion: Our results reveal that the rs895819 variant in miR-27a and rs11614913 in miR-196a2 have a substantial impact on the development of CRC. </Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Cancer Risk</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Colorectal cancer</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">miR-146a</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">miR-196a2</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">miR-27a</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">TNM stage</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>